Researchers found that brain imaging could detect changes linked to Alzheimer's disease more than seven years earlier than previously thought. A study from the University of Oslo indicates that the current imaging method, known as amyloid-PET, may not be sensitive enough to identify some of the earliest brain changes associated with Alzheimer's, which include structural changes that occur before amyloid plaques become visible. This discovery could pave the way for earlier detection of the disease, potentially improving treatment outcomes.

This finding is particularly relevant for people concerned about aging and cognitive decline. By identifying brain changes long before the typical signs of Alzheimer's appear, such as memory loss or confusion, individuals may have a better chance to address their brain health proactively. The study followed healthy individuals over nearly 20 years, revealing that structural changes in the brain can signal the onset of Alzheimer's years before symptoms emerge. This could lead to earlier interventions that might help maintain cognitive function.

The research is based on long-term MRI scans of participants, making it a significant step forward in understanding Alzheimer’s disease. However, while the results are promising, they are still in the early stages. The study suggests that harmful processes in the brain may start well before amyloid plaques are detectable, indicating that more research is needed to explore other biological factors involved in the disease. This could influence future Alzheimer’s treatments, emphasizing the need to develop therapies that target mechanisms beyond just plaque accumulation.